基于牛的混合药物作为潜在的抗癌治疗剂:体外,体外评估
Saltanat Nakypova1, Andrey Smolobochkin2, Tanzilya Rizbayeva2
1Faculty of Chemistry and Chemical Technology, Al Farabi Kazakh National University, Al-Farabi Avenue 71, Almaty 050040, Kazakhstan.
Pharmaceuticals (Basel, Switzerland)
|July 30, 2025
概括
基于牛的混合结构显示出作为新的抗瘤剂的前景. 化合物4p对癌细胞产生显著的抗增殖作用,并改善了小鼠的存活率,这表明药物发现的潜在支架.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 有机合成 有机合成
背景情况:
- 开发对正常细胞具有低毒性的抗瘤药物仍然是一个重大挑战.
- 氨酸的氨酸被探索为新型治疗化合物的基础.
- 混合结构正在研究其潜在的抗癌特性.
研究的目的:
- 为了合成和评估抗瘤活性的新型 taurine 衍生混合结构.
- 为了识别具有强大的抗增殖作用和低毒性的化合物.
- 评估有前途的候选药物的体内抗白血病疗效.
主要方法:
- 合成26种基于牛素的混合化合物.
- 使用核磁共振 (NMR) 和X射线衍光测量进行结构确认.
- 在体外细胞毒性测试对三个人类癌细胞系和正常细胞进行了测试.
- 在体内对BDF1小鼠进行抗白血病活性测试.
主要成果:
- 化合物4p对HL-60细胞 (IC50 = 76.7μM) 具有最强的抗增殖活性,具有有利的选择性指数 (IC50正常细胞 = 176.3μM).
- 氨酸的水溶性衍生物,特别是4p化合物,在体内表现出显著的抗白血病活性.
- 与对照组相比,化合物4p增加了患有瘤的小鼠的平均存活时间40%至100%.
结论:
- 基于牛的混合结构代表了开发新型抗增殖剂的有希望的支架.
- 化合物4p被确定为一种化合物,有可能在癌症治疗中进行进一步研究.
- 这项研究强调了修改氨基酸的治疗潜力,如氨酸用于药物发现.
关键词:
抗癌剂是一种抗癌剂.阿扎-迈克尔反应皮罗利丁胺是什么?taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine 是一种类型的氨基酸更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.3K
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.8K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
